

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.61610707 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.61610707 |
| 3 | regulation of vitamin metabolic process (GO:0030656) | 4.55697427 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15226969 |
| 5 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.93901750 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.86068796 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 3.77965213 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.72094812 |
| 9 | intestinal absorption (GO:0050892) | 3.56857784 |
| 10 | phospholipid efflux (GO:0033700) | 3.54039658 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 3.49265295 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 3.35840242 |
| 13 | regulation of triglyceride catabolic process (GO:0010896) | 3.35505946 |
| 14 | positive regulation of type 2 immune response (GO:0002830) | 3.32970154 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 3.24893119 |
| 16 | angiotensin maturation (GO:0002003) | 3.23453947 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 3.22897867 |
| 18 | plasma lipoprotein particle assembly (GO:0034377) | 3.22140900 |
| 19 | T-helper 1 type immune response (GO:0042088) | 3.21954557 |
| 20 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.19599623 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18491953 |
| 22 | urea cycle (GO:0000050) | 3.12481219 |
| 23 | urea metabolic process (GO:0019627) | 3.12481219 |
| 24 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.11955807 |
| 25 | plasma lipoprotein particle clearance (GO:0034381) | 3.10057530 |
| 26 | glycosphingolipid catabolic process (GO:0046479) | 3.09088062 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 3.07347357 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 3.03923975 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 3.03104421 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 3.03104421 |
| 31 | tryptophan catabolic process (GO:0006569) | 3.03104421 |
| 32 | negative regulation of sterol transport (GO:0032372) | 3.03092602 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 3.03092602 |
| 34 | glycolipid catabolic process (GO:0019377) | 3.00527797 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00374240 |
| 36 | bile acid and bile salt transport (GO:0015721) | 2.99146321 |
| 37 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.98126548 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 2.98106956 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96764561 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 2.96764561 |
| 41 | macromolecular complex remodeling (GO:0034367) | 2.96764561 |
| 42 | kynurenine metabolic process (GO:0070189) | 2.96011016 |
| 43 | reactive oxygen species biosynthetic process (GO:1903409) | 2.95789473 |
| 44 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.93139139 |
| 45 | response to peptidoglycan (GO:0032494) | 2.91604806 |
| 46 | protein-lipid complex assembly (GO:0065005) | 2.91112766 |
| 47 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.90854691 |
| 48 | tryptophan metabolic process (GO:0006568) | 2.89363984 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87785763 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87785763 |
| 51 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.87323766 |
| 52 | eosinophil chemotaxis (GO:0048245) | 2.86351892 |
| 53 | cholesterol efflux (GO:0033344) | 2.85440258 |
| 54 | flavonoid metabolic process (GO:0009812) | 2.85097197 |
| 55 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.84481939 |
| 56 | reverse cholesterol transport (GO:0043691) | 2.83276068 |
| 57 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82921374 |
| 58 | aromatic amino acid family catabolic process (GO:0009074) | 2.82641181 |
| 59 | cellular response to interferon-beta (GO:0035458) | 2.80834994 |
| 60 | response to type I interferon (GO:0034340) | 2.79221231 |
| 61 | nitrogen cycle metabolic process (GO:0071941) | 2.79110073 |
| 62 | cellular response to type I interferon (GO:0071357) | 2.78843094 |
| 63 | type I interferon signaling pathway (GO:0060337) | 2.78843094 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76989861 |
| 65 | positive regulation of pseudopodium assembly (GO:0031274) | 2.76230262 |
| 66 | virion attachment to host cell (GO:0019062) | 2.76162083 |
| 67 | adhesion of symbiont to host cell (GO:0044650) | 2.76162083 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.75409179 |
| 69 | L-phenylalanine metabolic process (GO:0006558) | 2.75409179 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 2.74090952 |
| 71 | lipoprotein metabolic process (GO:0042157) | 2.73770305 |
| 72 | response to interferon-beta (GO:0035456) | 2.73495177 |
| 73 | killing of cells of other organism (GO:0031640) | 2.73164109 |
| 74 | disruption of cells of other organism (GO:0044364) | 2.73164109 |
| 75 | respiratory burst (GO:0045730) | 2.72749432 |
| 76 | modulation by symbiont of host immune response (GO:0052553) | 2.71640050 |
| 77 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71640050 |
| 78 | modulation by symbiont of host defense response (GO:0052031) | 2.71640050 |
| 79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71640050 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71640050 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71640050 |
| 82 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.71380270 |
| 83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71077554 |
| 84 | neutrophil activation (GO:0042119) | 2.70796293 |
| 85 | regulation of cellular extravasation (GO:0002691) | 2.70150543 |
| 86 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70140261 |
| 87 | L-phenylalanine catabolic process (GO:0006559) | 2.70042637 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.70042637 |
| 89 | plasma lipoprotein particle organization (GO:0071827) | 2.69459989 |
| 90 | regulation of cholesterol storage (GO:0010885) | 2.68937308 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.68681416 |
| 92 | protein carboxylation (GO:0018214) | 2.68681416 |
| 93 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.68421639 |
| 94 | regulation of chronic inflammatory response (GO:0002676) | 2.67862030 |
| 95 | cellular glucuronidation (GO:0052695) | 2.66798476 |
| 96 | complement activation, alternative pathway (GO:0006957) | 2.66717372 |
| 97 | sulfur amino acid catabolic process (GO:0000098) | 2.65761052 |
| 98 | regulation of antigen processing and presentation (GO:0002577) | 2.65688615 |
| 99 | low-density lipoprotein particle remodeling (GO:0034374) | 2.65224612 |
| 100 | granulocyte activation (GO:0036230) | 2.64680221 |
| 101 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.64330957 |
| 102 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.64330957 |
| 103 | cellular response to exogenous dsRNA (GO:0071360) | 2.63940423 |
| 104 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.63838359 |
| 105 | alpha-linolenic acid metabolic process (GO:0036109) | 2.63647113 |
| 106 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60804773 |
| 107 | positive regulation of tolerance induction (GO:0002645) | 2.59482234 |
| 108 | cholesterol homeostasis (GO:0042632) | 2.58341968 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 2.58158688 |
| 110 | hormone catabolic process (GO:0042447) | 2.58103825 |
| 111 | phospholipid homeostasis (GO:0055091) | 2.57775894 |
| 112 | uronic acid metabolic process (GO:0006063) | 2.57123078 |
| 113 | glucuronate metabolic process (GO:0019585) | 2.57123078 |
| 114 | regulation of podosome assembly (GO:0071801) | 2.56630916 |
| 115 | response to muramyl dipeptide (GO:0032495) | 2.56267752 |
| 116 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56187280 |
| 117 | regulation of T cell tolerance induction (GO:0002664) | 2.56167615 |
| 118 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55729248 |
| 119 | regulation of metalloenzyme activity (GO:0048552) | 2.55670835 |
| 120 | negative regulation of viral genome replication (GO:0045071) | 2.55451467 |
| 121 | cellular response to interferon-gamma (GO:0071346) | 2.55361214 |
| 122 | protein-lipid complex subunit organization (GO:0071825) | 2.54842421 |
| 123 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.54744332 |
| 124 | interferon-gamma secretion (GO:0072643) | 2.54028024 |
| 125 | sterol homeostasis (GO:0055092) | 2.53500726 |
| 126 | myeloid dendritic cell differentiation (GO:0043011) | 2.52730697 |
| 127 | ceramide catabolic process (GO:0046514) | 2.52605014 |
| 128 | regulation of activation of Janus kinase activity (GO:0010533) | 2.52106250 |
| 129 | desmosome organization (GO:0002934) | 2.51154725 |
| 130 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.50781335 |
| 131 | eosinophil migration (GO:0072677) | 2.49591829 |
| 132 | regulation of RIG-I signaling pathway (GO:0039535) | 2.49529650 |
| 133 | response to fungus (GO:0009620) | 2.49195928 |
| 134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.48636987 |
| 135 | regulation of tolerance induction (GO:0002643) | 2.48239185 |
| 136 | acute-phase response (GO:0006953) | 2.47650592 |
| 137 | regulation of chemokine biosynthetic process (GO:0045073) | 2.45860301 |
| 138 | negative regulation of interleukin-12 production (GO:0032695) | 2.45645468 |
| 139 | negative regulation of cell killing (GO:0031342) | 2.45135665 |
| 140 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.45135665 |
| 141 | positive regulation of neutrophil migration (GO:1902624) | 2.44645484 |
| 142 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.44645484 |
| 143 | adhesion of symbiont to host (GO:0044406) | 2.41864625 |
| 144 | regulation of pseudopodium assembly (GO:0031272) | 2.41642718 |
| 145 | response to interferon-gamma (GO:0034341) | 2.41003274 |
| 146 | B cell mediated immunity (GO:0019724) | 2.39914447 |
| 147 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.39008197 |
| 148 | sexual reproduction (GO:0019953) | 2.38979876 |
| 149 | lymphocyte chemotaxis (GO:0048247) | 2.37360758 |
| 150 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.36884390 |
| 151 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.32327009 |
| 152 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.32231702 |
| 153 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.31687675 |
| 154 | macrophage activation involved in immune response (GO:0002281) | 2.31373294 |
| 155 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.30087518 |
| 156 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.29193436 |
| 157 | GDP-mannose metabolic process (GO:0019673) | 2.28977355 |
| 158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.28965142 |
| 159 | regulation of regulatory T cell differentiation (GO:0045589) | 2.28298558 |
| 160 | negative regulation of T cell mediated immunity (GO:0002710) | 2.27757476 |
| 161 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.27561871 |
| 162 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.26955058 |
| 163 | germinal center formation (GO:0002467) | 2.26458445 |
| 164 | membrane lipid catabolic process (GO:0046466) | 2.25199941 |
| 165 | cellular response to interferon-alpha (GO:0035457) | 2.24875153 |
| 166 | thrombin receptor signaling pathway (GO:0070493) | 2.24112398 |
| 167 | regulation of type 2 immune response (GO:0002828) | 2.22507493 |
| 168 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22480387 |
| 169 | regulation of T cell chemotaxis (GO:0010819) | 2.21907875 |
| 170 | positive regulation of T cell chemotaxis (GO:0010820) | 2.21907875 |
| 171 | regulation of viral release from host cell (GO:1902186) | 2.20681060 |
| 172 | sphingolipid catabolic process (GO:0030149) | 2.20041506 |
| 173 | regulation of mononuclear cell migration (GO:0071675) | 2.19943547 |
| 174 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.19056800 |
| 175 | defense response to virus (GO:0051607) | 2.18827066 |
| 176 | myeloid dendritic cell activation (GO:0001773) | 2.18598810 |
| 177 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.16860954 |
| 178 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.16855907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.25723704 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.15315164 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.90107270 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.83699810 |
| 5 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.68798762 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.64640450 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49838093 |
| 8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.34691338 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.28488915 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.09760680 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83081410 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79571780 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58433487 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.56029512 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.51607692 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.48986611 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42455962 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40767737 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39617271 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.36964492 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36927776 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34913803 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.26120947 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.20909405 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02336706 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00521788 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.00474038 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98981948 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96242659 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89368083 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88287465 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88003682 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86769970 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85665992 |
| 35 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83464913 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79508329 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.72121143 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.69751005 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67628498 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66199698 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64346814 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59876937 |
| 43 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.59780469 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51804229 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46125619 |
| 46 | * MAF_26560356_Chip-Seq_TH1_Human | 1.43225407 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.40439709 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38986109 |
| 49 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38201826 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37726915 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37661923 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36972324 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36520527 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31872306 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29056848 |
| 56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28901910 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28836190 |
| 58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28430896 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28116649 |
| 60 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27735697 |
| 61 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.27021495 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26718321 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26303619 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25176790 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25090341 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.22969887 |
| 67 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22219004 |
| 68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.22202221 |
| 69 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20489665 |
| 70 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.19854542 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19654791 |
| 72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19436606 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19436606 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16111869 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14104361 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14081426 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11709433 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11586151 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10659099 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10582249 |
| 81 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.08860881 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08488703 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07148147 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05741788 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03731567 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02803824 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02401969 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02358531 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01476071 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01395901 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01173805 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01024769 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98164724 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97855823 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97615827 |
| 96 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96742939 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96538461 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96008707 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95383882 |
| 100 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95334530 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94355606 |
| 102 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93717844 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93567328 |
| 104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93333020 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92837372 |
| 106 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92261181 |
| 107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91086938 |
| 108 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90745303 |
| 109 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.90327940 |
| 110 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89771071 |
| 111 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88443363 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88250556 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86781093 |
| 114 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86545741 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86311947 |
| 116 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85505515 |
| 117 | MYC_22102868_ChIP-Seq_BL_Human | 0.85487012 |
| 118 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84827827 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83906687 |
| 120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83906244 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83325646 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82947440 |
| 123 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82621251 |
| 124 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82521870 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82397674 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82069257 |
| 127 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81958859 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81798623 |
| 129 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81743586 |
| 130 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.78141416 |
| 131 | MAF_26560356_Chip-Seq_TH2_Human | 0.78026873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.95809562 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.69662129 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.01853733 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.01468002 |
| 5 | MP0009785_altered_susceptibility_to | 2.91822770 |
| 6 | MP0003436_decreased_susceptibility_to | 2.75772799 |
| 7 | MP0005365_abnormal_bile_salt | 2.69753778 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.57132198 |
| 9 | MP0009840_abnormal_foam_cell | 2.50101258 |
| 10 | MP0003252_abnormal_bile_duct | 2.41838475 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.30185391 |
| 12 | MP0003724_increased_susceptibility_to | 2.28128294 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.26542683 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.21134297 |
| 15 | MP0005025_abnormal_response_to | 2.19993129 |
| 16 | MP0003303_peritoneal_inflammation | 2.06513853 |
| 17 | MP0002419_abnormal_innate_immunity | 2.06414641 |
| 18 | MP0000685_abnormal_immune_system | 2.03905118 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.99293265 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.97818924 |
| 21 | MP0010155_abnormal_intestine_physiology | 1.97040323 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.91390506 |
| 23 | MP0001853_heart_inflammation | 1.81319857 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.80329157 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.79358218 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.75411205 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.73277451 |
| 28 | MP0001790_abnormal_immune_system | 1.70709702 |
| 29 | MP0005387_immune_system_phenotype | 1.70709702 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.70403159 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.68839508 |
| 32 | MP0001800_abnormal_humoral_immune | 1.68536756 |
| 33 | MP0004947_skin_inflammation | 1.68484542 |
| 34 | MP0009764_decreased_sensitivity_to | 1.66939206 |
| 35 | MP0002006_tumorigenesis | 1.63541181 |
| 36 | MP0002723_abnormal_immune_serum | 1.60580667 |
| 37 | MP0005671_abnormal_response_to | 1.58103213 |
| 38 | MP0006082_CNS_inflammation | 1.55737415 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.54137124 |
| 40 | MP0008469_abnormal_protein_level | 1.52487704 |
| 41 | MP0001819_abnormal_immune_cell | 1.49959487 |
| 42 | MP0009278_abnormal_bone_marrow | 1.49311779 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.47945374 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.47275717 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.47008940 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.47008940 |
| 47 | MP0003186_abnormal_redox_activity | 1.46876409 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.44650269 |
| 49 | MP0000609_abnormal_liver_physiology | 1.44221344 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.43546067 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.39469462 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.31875433 |
| 53 | MP0002405_respiratory_system_inflammati | 1.29216101 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.28509084 |
| 55 | MP0004019_abnormal_vitamin_homeostasis | 1.25190134 |
| 56 | MP0003866_abnormal_defecation | 1.22943495 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.22605713 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 1.22373487 |
| 59 | MP0003868_abnormal_feces_composition | 1.20927041 |
| 60 | MP0001873_stomach_inflammation | 1.17596210 |
| 61 | MP0005083_abnormal_biliary_tract | 1.17432586 |
| 62 | MP0000716_abnormal_immune_system | 1.12850414 |
| 63 | MP0009697_abnormal_copulation | 1.10749847 |
| 64 | MP0000490_abnormal_crypts_of | 1.10122158 |
| 65 | MP0009763_increased_sensitivity_to | 1.09980367 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.07936836 |
| 67 | MP0002398_abnormal_bone_marrow | 1.07855697 |
| 68 | MP0005165_increased_susceptibility_to | 1.06252077 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.05388377 |
| 70 | MP0000858_altered_metastatic_potential | 1.05269128 |
| 71 | MP0006054_spinal_hemorrhage | 1.03737366 |
| 72 | MP0003091_abnormal_cell_migration | 1.03182903 |
| 73 | MP0005332_abnormal_amino_acid | 1.01382031 |
| 74 | MP0005164_abnormal_response_to | 1.00581564 |
| 75 | MP0002429_abnormal_blood_cell | 1.00139989 |
| 76 | MP0004043_abnormal_pH_regulation | 1.00068643 |
| 77 | MP0000689_abnormal_spleen_morphology | 0.97428499 |
| 78 | MP0001764_abnormal_homeostasis | 0.97247983 |
| 79 | MP0003448_altered_tumor_morphology | 0.96915878 |
| 80 | MP0002722_abnormal_immune_system | 0.93951968 |
| 81 | MP0005023_abnormal_wound_healing | 0.93740153 |
| 82 | MP0002254_reproductive_system_inflammat | 0.93689711 |
| 83 | MP0003075_altered_response_to | 0.93301097 |
| 84 | MP0000598_abnormal_liver_morphology | 0.93054273 |
| 85 | MP0002396_abnormal_hematopoietic_system | 0.92854481 |
| 86 | MP0002132_abnormal_respiratory_system | 0.92718958 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.92650736 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.92525957 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90560510 |
| 90 | MP0001663_abnormal_digestive_system | 0.89103656 |
| 91 | MP0005166_decreased_susceptibility_to | 0.87125752 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.86979469 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.85474337 |
| 94 | MP0000343_altered_response_to | 0.85091561 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.84412632 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.83407372 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.83324411 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.82411913 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.81730235 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.80706102 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.80312553 |
| 102 | MP0002796_impaired_skin_barrier | 0.80152365 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.79266234 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.77959022 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.77875143 |
| 106 | MP0000249_abnormal_blood_vessel | 0.77157624 |
| 107 | MP0010678_abnormal_skin_adnexa | 0.77089813 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.76958489 |
| 109 | MP0005310_abnormal_salivary_gland | 0.76919964 |
| 110 | MP0008004_abnormal_stomach_pH | 0.76635339 |
| 111 | MP0003950_abnormal_plasma_membrane | 0.75366783 |
| 112 | MP0000477_abnormal_intestine_morphology | 0.74477530 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.74002776 |
| 114 | MP0002933_joint_inflammation | 0.73783703 |
| 115 | MP0005670_abnormal_white_adipose | 0.73026764 |
| 116 | MP0010307_abnormal_tumor_latency | 0.72994856 |
| 117 | MP0004883_abnormal_blood_vessel | 0.72840503 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.71697970 |
| 119 | MP0008873_increased_physiological_sensi | 0.71402410 |
| 120 | MP0005451_abnormal_body_composition | 0.71232292 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.70883331 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.70704422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.15104391 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.10248724 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.07511206 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 3.99265951 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86215281 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.76626956 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.74600823 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.66903091 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.66035079 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.56420951 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.27314413 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.24311876 |
| 13 | Xanthomatosis (HP:0000991) | 3.14238123 |
| 14 | Myositis (HP:0100614) | 3.13599241 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.13222312 |
| 16 | Orchitis (HP:0100796) | 3.13019574 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.06334229 |
| 18 | Petechiae (HP:0000967) | 3.05955342 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.04021951 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03999074 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.03919483 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.01881138 |
| 23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.01290628 |
| 24 | Hyperactive renin-angiotensin system (HP:0000841) | 2.99201418 |
| 25 | Keratoconjunctivitis (HP:0001096) | 2.98941400 |
| 26 | Increased IgM level (HP:0003496) | 2.95196702 |
| 27 | Malnutrition (HP:0004395) | 2.94290418 |
| 28 | Pustule (HP:0200039) | 2.92105329 |
| 29 | Joint hemorrhage (HP:0005261) | 2.90567906 |
| 30 | Esophageal varix (HP:0002040) | 2.81709924 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.79967191 |
| 32 | Optic neuritis (HP:0100653) | 2.78771158 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.78771158 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.74507588 |
| 35 | Fat malabsorption (HP:0002630) | 2.73666845 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.73299697 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 2.73299697 |
| 38 | Hemoptysis (HP:0002105) | 2.72840723 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.70570962 |
| 40 | Hypoglycemic seizures (HP:0002173) | 2.66458602 |
| 41 | Chronic otitis media (HP:0000389) | 2.66195085 |
| 42 | Recurrent viral infections (HP:0004429) | 2.62602830 |
| 43 | Gingivitis (HP:0000230) | 2.59813648 |
| 44 | Vasculitis (HP:0002633) | 2.59238097 |
| 45 | Gangrene (HP:0100758) | 2.58697055 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.58000005 |
| 47 | Flat acetabular roof (HP:0003180) | 2.54827011 |
| 48 | Gingival bleeding (HP:0000225) | 2.52675960 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51955366 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51955366 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51955366 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.51540616 |
| 53 | Pigmentary retinal degeneration (HP:0001146) | 2.48843563 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.48014509 |
| 55 | Periodontitis (HP:0000704) | 2.47820585 |
| 56 | Hyperammonemia (HP:0001987) | 2.46575539 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.44668489 |
| 58 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44455102 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.41822420 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.41327936 |
| 61 | Acanthocytosis (HP:0001927) | 2.41108840 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.40007909 |
| 63 | Myocardial infarction (HP:0001658) | 2.39367646 |
| 64 | Thrombophlebitis (HP:0004418) | 2.38325865 |
| 65 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.36304359 |
| 66 | Villous atrophy (HP:0011473) | 2.36304359 |
| 67 | Arterial thrombosis (HP:0004420) | 2.34049402 |
| 68 | Recurrent skin infections (HP:0001581) | 2.31407830 |
| 69 | Polycythemia (HP:0001901) | 2.31270869 |
| 70 | Thrombocytosis (HP:0001894) | 2.30444037 |
| 71 | Epidermoid cyst (HP:0200040) | 2.25281130 |
| 72 | Abnormal platelet volume (HP:0011876) | 2.25025581 |
| 73 | Complement deficiency (HP:0004431) | 2.24905338 |
| 74 | Ileus (HP:0002595) | 2.24485852 |
| 75 | Peritonitis (HP:0002586) | 2.24422849 |
| 76 | Encephalitis (HP:0002383) | 2.24191686 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.23596295 |
| 78 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.23508331 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.21401794 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.20803422 |
| 81 | Urticaria (HP:0001025) | 2.20458667 |
| 82 | Increased mean platelet volume (HP:0011877) | 2.17014012 |
| 83 | Abnormality of T cell number (HP:0011839) | 2.16655548 |
| 84 | Epistaxis (HP:0000421) | 2.16502392 |
| 85 | Chronic diarrhea (HP:0002028) | 2.13479457 |
| 86 | Abnormality of B cell number (HP:0010975) | 2.13332309 |
| 87 | Pulmonary embolism (HP:0002204) | 2.12868655 |
| 88 | Hyperbilirubinemia (HP:0002904) | 2.12116830 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11562263 |
| 90 | Colitis (HP:0002583) | 2.11533743 |
| 91 | Leukocytosis (HP:0001974) | 2.09302376 |
| 92 | Nausea (HP:0002018) | 2.09192542 |
| 93 | Nephritis (HP:0000123) | 2.09137728 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.09049231 |
| 95 | Congenital sensorineural hearing impairment (HP:0008527) | 2.08851385 |
| 96 | Hematochezia (HP:0002573) | 2.08661389 |
| 97 | Menorrhagia (HP:0000132) | 2.08125832 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 2.07382957 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 2.05456178 |
| 100 | Cellulitis (HP:0100658) | 2.05205863 |
| 101 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04810296 |
| 102 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04810296 |
| 103 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04718589 |
| 104 | Purpura (HP:0000979) | 2.04370606 |
| 105 | Basal ganglia calcification (HP:0002135) | 2.03390068 |
| 106 | Meningitis (HP:0001287) | 2.02947644 |
| 107 | Poikilocytosis (HP:0004447) | 2.02640494 |
| 108 | Hyperlipoproteinemia (HP:0010980) | 2.01990558 |
| 109 | Combined immunodeficiency (HP:0005387) | 2.01818192 |
| 110 | Glomerulonephritis (HP:0000099) | 2.01428861 |
| 111 | Abnormality of the intrinsic pathway (HP:0010989) | 2.01407180 |
| 112 | Pulmonary infiltrates (HP:0002113) | 2.01118283 |
| 113 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.00910078 |
| 114 | Abnormality of complement system (HP:0005339) | 2.00173086 |
| 115 | Stomatitis (HP:0010280) | 1.99551030 |
| 116 | Pancreatitis (HP:0001733) | 1.99210465 |
| 117 | Abnormality of the pleura (HP:0002103) | 1.98982897 |
| 118 | Joint swelling (HP:0001386) | 1.97712777 |
| 119 | Granulocytopenia (HP:0001913) | 1.96933237 |
| 120 | Thin bony cortex (HP:0002753) | 1.96223189 |
| 121 | Abnormal tarsal ossification (HP:0008369) | 1.95707960 |
| 122 | Abnormality of the nasal mucosa (HP:0000433) | 1.95448314 |
| 123 | Symptomatic seizures (HP:0011145) | 1.95361010 |
| 124 | Abdominal distention (HP:0003270) | 1.94831632 |
| 125 | Amyloidosis (HP:0011034) | 1.94795096 |
| 126 | Anorexia (HP:0002039) | 1.94256951 |
| 127 | Abnormal glucose tolerance (HP:0001952) | 1.93951240 |
| 128 | Cheilitis (HP:0100825) | 1.93159057 |
| 129 | Bronchitis (HP:0012387) | 1.92958540 |
| 130 | Nasal polyposis (HP:0100582) | 1.92765410 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.92238286 |
| 132 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.91735377 |
| 133 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91619650 |
| 134 | Hyperparathyroidism (HP:0000843) | 1.91525501 |
| 135 | Abnormality of the pericardium (HP:0001697) | 1.91137495 |
| 136 | Decreased circulating renin level (HP:0003351) | 1.87407677 |
| 137 | Alkalosis (HP:0001948) | 1.86978653 |
| 138 | Metabolic alkalosis (HP:0200114) | 1.84504418 |
| 139 | Glucose intolerance (HP:0000833) | 1.84273307 |
| 140 | Osteolytic defects of the hand bones (HP:0009699) | 1.83450414 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83450414 |
| 142 | Abnormality of T cells (HP:0002843) | 1.83239683 |
| 143 | Loss of speech (HP:0002371) | 1.82576455 |
| 144 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82043397 |
| 145 | Inflammation of the large intestine (HP:0002037) | 1.81722360 |
| 146 | Dysostosis multiplex (HP:0000943) | 1.81670693 |
| 147 | Steatorrhea (HP:0002570) | 1.80721487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 3.26900861 |
| 2 | MAP3K14 | 3.23282271 |
| 3 | TAOK3 | 3.04115135 |
| 4 | MAP3K12 | 2.98279729 |
| 5 | BLK | 2.84066965 |
| 6 | EPHA2 | 2.67140367 |
| 7 | MST1R | 2.53340825 |
| 8 | TYK2 | 2.51161553 |
| 9 | MAP3K10 | 2.47924927 |
| 10 | MAP4K1 | 2.42338027 |
| 11 | MST4 | 2.40109366 |
| 12 | ERN1 | 2.36429895 |
| 13 | IKBKE | 2.33747633 |
| 14 | FRK | 2.30314966 |
| 15 | KDR | 2.19609747 |
| 16 | IRAK4 | 2.15784100 |
| 17 | RIPK4 | 2.13096305 |
| 18 | JAK3 | 2.01966663 |
| 19 | IKBKB | 1.98279303 |
| 20 | PBK | 1.74948926 |
| 21 | PRPF4B | 1.65586815 |
| 22 | IRAK3 | 1.59016652 |
| 23 | KIT | 1.50139811 |
| 24 | STK10 | 1.44937419 |
| 25 | FLT3 | 1.44535502 |
| 26 | BTK | 1.44192428 |
| 27 | FGFR4 | 1.43856377 |
| 28 | GRK6 | 1.42428036 |
| 29 | PKN2 | 1.42414455 |
| 30 | PIM2 | 1.42284545 |
| 31 | BCKDK | 1.40946462 |
| 32 | TEC | 1.37372412 |
| 33 | GRK7 | 1.37247652 |
| 34 | TESK2 | 1.37189682 |
| 35 | JAK1 | 1.35993293 |
| 36 | ZAP70 | 1.35892327 |
| 37 | MAP2K3 | 1.32463106 |
| 38 | TXK | 1.32458850 |
| 39 | TIE1 | 1.26666726 |
| 40 | TGFBR1 | 1.26045763 |
| 41 | TESK1 | 1.22476111 |
| 42 | NME2 | 1.17673038 |
| 43 | CHUK | 1.17040440 |
| 44 | NEK9 | 1.15918486 |
| 45 | TAOK2 | 1.15817468 |
| 46 | PRKG2 | 1.15812627 |
| 47 | PIM1 | 1.15099165 |
| 48 | FGR | 1.14604081 |
| 49 | PTK6 | 1.09659824 |
| 50 | RPS6KA4 | 1.08329910 |
| 51 | BMX | 1.08323842 |
| 52 | TGFBR2 | 1.06464585 |
| 53 | CSK | 1.05549843 |
| 54 | JAK2 | 1.03289206 |
| 55 | MAP2K2 | 1.02877855 |
| 56 | EIF2AK1 | 1.02714673 |
| 57 | LRRK2 | 1.02144610 |
| 58 | EPHB2 | 1.01828827 |
| 59 | MATK | 1.01606620 |
| 60 | FER | 0.98673504 |
| 61 | DDR2 | 0.97656408 |
| 62 | ABL2 | 0.95939220 |
| 63 | TRPM7 | 0.95002113 |
| 64 | SYK | 0.94481762 |
| 65 | ACVR1B | 0.88868913 |
| 66 | SIK1 | 0.88750788 |
| 67 | RIPK1 | 0.88220956 |
| 68 | EPHA3 | 0.86899643 |
| 69 | CSF1R | 0.86816575 |
| 70 | MET | 0.86306552 |
| 71 | LYN | 0.86153660 |
| 72 | NEK1 | 0.83481004 |
| 73 | MAP3K11 | 0.83382091 |
| 74 | LMTK2 | 0.81856280 |
| 75 | PDK2 | 0.80237023 |
| 76 | ITK | 0.79494505 |
| 77 | MAPK11 | 0.78136979 |
| 78 | MAP3K13 | 0.77803950 |
| 79 | LCK | 0.72290529 |
| 80 | MAP3K1 | 0.71414166 |
| 81 | YES1 | 0.69259849 |
| 82 | NLK | 0.68828829 |
| 83 | MARK3 | 0.68808757 |
| 84 | PIK3CG | 0.67254633 |
| 85 | TLK1 | 0.66345698 |
| 86 | MAP3K8 | 0.66320181 |
| 87 | BMPR2 | 0.66117715 |
| 88 | IRAK1 | 0.65826282 |
| 89 | FGFR3 | 0.65820421 |
| 90 | CDK4 | 0.64481369 |
| 91 | CDK6 | 0.63983280 |
| 92 | EIF2AK2 | 0.61739805 |
| 93 | CDK9 | 0.61435499 |
| 94 | STK4 | 0.61078444 |
| 95 | CLK1 | 0.61011711 |
| 96 | ADRBK2 | 0.60232438 |
| 97 | FES | 0.59218087 |
| 98 | MAP3K3 | 0.58419444 |
| 99 | CDC42BPA | 0.56177858 |
| 100 | MUSK | 0.56154153 |
| 101 | MAP3K5 | 0.52664531 |
| 102 | PRKCD | 0.52208076 |
| 103 | RPS6KB2 | 0.51750396 |
| 104 | MOS | 0.51667097 |
| 105 | STK39 | 0.50251716 |
| 106 | NUAK1 | 0.49406470 |
| 107 | PAK4 | 0.49095539 |
| 108 | MAP2K6 | 0.48769705 |
| 109 | MAPK4 | 0.47696496 |
| 110 | SCYL2 | 0.46808707 |
| 111 | TRIB3 | 0.46288355 |
| 112 | GRK1 | 0.45694056 |
| 113 | PDPK1 | 0.44939061 |
| 114 | ABL1 | 0.44514701 |
| 115 | MELK | 0.42704442 |
| 116 | EPHB1 | 0.42211732 |
| 117 | DAPK1 | 0.42143985 |
| 118 | SMG1 | 0.41395428 |
| 119 | WEE1 | 0.38648582 |
| 120 | HCK | 0.38439608 |
| 121 | MAPKAPK2 | 0.37744992 |
| 122 | WNK4 | 0.37403548 |
| 123 | PIK3CA | 0.37076916 |
| 124 | EGFR | 0.36276449 |
| 125 | EIF2AK3 | 0.35431555 |
| 126 | CDK7 | 0.35202799 |
| 127 | STK3 | 0.34187806 |
| 128 | MYLK | 0.34172178 |
| 129 | STK24 | 0.33129591 |
| 130 | PRKCQ | 0.32292490 |
| 131 | BRSK2 | 0.29851027 |
| 132 | RPS6KA6 | 0.27901505 |
| 133 | ERBB4 | 0.27654329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60208258 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.82951620 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.60311725 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.46088494 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46024307 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39289838 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23870569 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.21652313 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96638540 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95078397 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.92580992 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84157974 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.83894843 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80433361 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75322967 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70891188 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70879733 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68268877 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63683626 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60421294 |
| 21 | * Legionellosis_Homo sapiens_hsa05134 | 1.59759492 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56563533 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52382043 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49000145 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46047548 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.44192334 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41192627 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36959621 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32788670 |
| 30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.32092132 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.30833109 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30529544 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30406188 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27769886 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26166204 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.25285496 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24050273 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23484627 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21101626 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20162482 |
| 41 | * Pertussis_Homo sapiens_hsa05133 | 1.19017288 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.17105497 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12973431 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11919916 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.11185961 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11011058 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.09490171 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.08797461 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.07582966 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07170133 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.01772227 |
| 52 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.00575992 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99423038 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99333893 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99255255 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99032081 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98606770 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97884869 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.93866277 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.88809461 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88141439 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85446051 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.84792979 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83751632 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82302223 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81986460 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81127960 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79996736 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.79784394 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79462340 |
| 71 | Proteasome_Homo sapiens_hsa03050 | 0.78433567 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77961483 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75377201 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74573920 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73865992 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72379580 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.71881733 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.71150452 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70039673 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69657718 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68861641 |
| 82 | * Apoptosis_Homo sapiens_hsa04210 | 0.64588820 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64133277 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.64018257 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62858212 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62628248 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62326692 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60852399 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60749402 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60593006 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.58897052 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58674590 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58580692 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58282659 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58165421 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.57699987 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57001246 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56292349 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53130598 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53086283 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52787782 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.51384388 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50366343 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.50360668 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.48565924 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47727253 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46888756 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46216088 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45593510 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44647265 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44534600 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.44463976 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44275537 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43302959 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42270440 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.41701427 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40644505 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39500004 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39342044 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38463818 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37073227 |
| 122 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36963908 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36567774 |

